BhartiyaD, ShaikhA, NagvenkarP, KasiviswanathanS, PetheP, PawaniH, MohantyS, RaoSG, ZaveriK, HindujaI. 2012. Very small embryonic-like stem cells with maximum regenerative potential get discarded during cord blood banking and bone marrow processing for autologous stem cell therapy. Stem Cells Dev, 21:1–6.
2.
RatajczakJ, Zuba-SurmaE, KlichI, LiuR, WysoczynskiM, GrecoN, KuciaM, LaughlinMJ, RatajczakMZ. 2011. Hematopoietic differentiation of umbilical cord blood-derived very small embryonic/epiblast-like stem cells. Leukemia, 25:1278–1285.
3.
GammaitoniL, LucchiS, BrunoS, TesioM, GunettiM, PignochinoY, MigliardiG, LazzariL, AgliettaM, RebullaP, PiacibelloW. 2006. Serial transplantations in nonobese diabetic/severe combined immunodeficiency mice of transduced human CD34+ cord blood cells: efficient oncoretroviral gene transfer and ex vivo expansion under serum-free conditions. Stem Cells, 24:1201–1212.
4.
IvanovicZ, DuchezP, ChevaleyreJ, VlaskiM, LafargeX, DazeyB, Robert-RichardE, MazurierF, BoironJM. 2011. Clinical-scale cultures of cord blood CD34(+) cells to amplify committed progenitors and maintain stem cell activity. Cell Transplant, 20:1453–1463.
5.
SinghK, SrivastavaA, MathurN, KumarS, KumarL, MukhopadhyayA, KonchupillaiV. 2009. Evaluation of four methods for processing human cord blood and subsequent study of the expansion of progenitor stem cells isolated using the best method. Cythotherapy, 11:768–777.
6.
DazeyB, DuchezP, LetellierC, VezonG, IvanovicZ. 2005. Cord blood processing by using a standard manual technique and automated closed system “Sepax” (kit CS-530)Stem Cells Dev, 14:6–10.
